Helmedix

N/A

Report date: 2025/01/26 19:20:33

Base Information

Drug NameHelmedix
Drug Alias NameFasciola hepatica-derived peptides (University of Technology Sydney)Helminth Defence Molecules
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMacrophages modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A